03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Eberelbine 50mg : | |
Type | Medicine Authorised |
Originator | Navelbine Injectable 50mg |
Agent | Khalil Fattal & Fils |
Distributor | Khalil Fattal & Fils |
Laboratory | Ebewe |
Responsible Party | Ebewe Pharma GesmbH.NFG.KG |
Origin | Austria |
Manufacturer | Fareva Unterach GmbH |
Manufacturing Type | G |
Origin | Austria |
ATC | L01CA04 |
Eberelbine 50mg :
Eberelbine 50mg :
Eberelbine 50mg :
Eberelbine 50mg :
Eberelbine 50mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Alopecia | Very Common |
Anaemia | Very Common |
Anaphylactic shock | Not known |
Anaphylactoid reactions | Not known |
Anaphylaxis | Not known |
Angina pectoris | Rare |
Anorexia | Not known |
Arrhythmia | Very rare |
Arthralgia (Pain joint) (Joint ache) | Common |
Asthenia | Common |
Bacterial infection | Common |
Bone marrow depression | Very Common |
Bronchospasm | Uncommon |
Chest pain | Common |
Cold extremities | Uncommon |
Constipation | Very Common |
Diarrhoea (Diarrhea) | Common |
Dyspnoea (dyspnea) | Uncommon |
Fatigue | Common |
Febrile neutropenia (Neutropenic fever) | Not known |
Fever | Common |
Flushing | Uncommon |
Fungal infection | Common |
Generalized skin reaction | Rare |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Not known |
Hypertension | Uncommon |
Hyponatraemia (Hyponatremia) | Rare |
Hypotension | Uncommon |
Ileus paralytic | Rare |
Inappropriate antidiuretic hormone secretion (SIADH) | Not known |
Injection site burning | Very Common |
Injection site erythema | Very Common |
Injection site necrosis | Rare |
Injection site phlebitis | Very Common |
Injection site vein discolouration | Very Common |
Interstitial pneumonitis | Rare |
Jaw pain | Common |
Liver function test increased | Very Common |
Loss of deep tendon reflexes | Very Common |
Myalgia | Common |
Myocardial infarction | Rare |
Nausea | Very Common |
Neutropenia | Very Common |
Neutropenia septic | Not known |
Palpitations | Very rare |
Pancytopenia | Not known |
Paraesthesia (paresthesia) | Uncommon |
Platelet count decreased (Thrombocyte count decreased) | Common |
Sepsis (Systemic infection) (Sepsis state) | Uncommon |
Septicemia | Uncommon |
Stomatitis | Very Common |
Tachycardia | Very rare |
Tumour site pain | Common |
Viral infection | Common |
Visceral failure | Uncommon |
Vomiting | Very Common |
Weakness of the lower extremities | Very Common |
Eberelbine 50mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Eberelbine 50mg MoH 5153 :
Form | Solution for infusion |
Packaging | Bottle |
Package Size | 1x5ml |
Strength | 50mg |
Public Price | 7844402.43 L.L. |
Stratum | C |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 222222/07 |
Submission date | 01/01/2007 |
Registration Year | 2008 |
Price Comparison
● Country: | Lebanon | |
● Form: | Solution for infusion | |
● Package Size: | 1x5ml | |
● Public Price: | 7844402.43 LBP | ( 7,844,402.43 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 7844402,43 LBP | ( 7,844,402.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | New Zealand |
● Package Size: | 1 inj |
● Exfactory Price: | 210 NZD |
● Reference: | New Zealand Pharmaceutical Management Agency |
● Pricing Date: | 01/01/2019 |
● Type: | Medicine Non Marketed |
You have to register to view this info
Drop File